US Wound Care Market

The report "US Wound Care Market by Product [Dressings (Foam, Hydrocolloid, Collagen), Devices (NPWT, Debridement), Biological Skin Substitutes, Sutures, Staplers], Wound [Chronic, Acute], End User [Hospitals, Clinics, Home Care]-Forecast to 2031"is projected to grow from USD 7.01 billion in 2026 and to reach USD 9.44 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period.

Browse 91 market data Tables and 41 Figures spread through 200 Pages and in-depth TOC on "US Wound Care Market by Product [Dressings (Foam, Hydrocolloid, Collagen), Devices (NPWT, Debridement), Biological Skin Substitutes, Sutures, Staplers], Wound [Chronic, Acute], End User [Hospitals, Clinics, Home Care]-Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/us-wound-care-market-131193251.html

The US wound care market is primarily fueled by a rise in the incidence of wounds, such as diabetic foot ulcers, pressure ulcers, and others, which demand more efficient approaches for their management. Apart from this, there is a rise in the incidence of traumas resulting from accidents, which translates into a higher demand for more efficient approaches for their management. The emerging markets are opening the gateways for their healthcare development.

In 2025, the chronic wounds specimens segment held the largest share of the US wound care market, by wound type.

The US wound care market, by wound type, is segmented into two categories: chronic wounds and acute wounds. The chronic wounds segment has been further categorized into diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other ulcers. The chronic wounds segment accounted for the largest share of the US wound care market in 2025. Chronic wounds have a higher incidence rate and require fast, effective treatment, which ultimately propels demand for such devices. Local infections can be prevented, and fast, effective healing can be promoted with the help of wound care products. Moreover, increasing numbers of surgical procedures, along with accidental injuries across the globe, are driving demand for acute wounds.

In 2025, the hospitals and clinics segment held the largest share of the US wound care market, by end user.

The US wound care market, by end user, has been classified into hospitals & clinics, home care settings, long-term care facilities, and other end users. Of these, in 2025, hospitals & clinics accounted for the largest share of the US wound care market. Hospitals & clinics can be further classified into inpatient and outpatient facilities. They account for a major share of the market because they have ready access to technology and expertise. They also see more serious cases involving wounds, which further increases their share. Additionally, they can offer continuous treatment, which boosts their position in the market.

The major players operating in this market are Solventum (US), Johnson & Johnson Services, Inc. (US), Smith+ Nephew (UK), Convatec Group PLC (UK), Coloplast Group (Denmark), Cardinal Health (US), Mölnlycke AB (Sweden), Integra LifeSciences Corporation (US), PAUL HARTMANN AG (Germany), B.Braun SE (Germany), Organogenesis Inc. (US), MIMEDX Group, Inc. (US), Essity Aktlebolag (Sweden), Avery Dennison Corporation (US), Mativ Holdings, Inc. (US), Owens & Minor (US), Zimmer Biomet (US), Bioventus (US), Medtronic (Ireland), and Baxter (US).

Don’t miss out on business opportunities in US Wound Care Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/